Dr Tu’uhevaha Kaitu’u-Lino is a senior research scientist with a focus on clinical translation.
She leads one of two subgroups of researchers working within Translational Obstetrics Group. The Translational Obstetrics Group is led by Prof. Stephen Tong, within the research arm of Mercy Perinatal.
Tu’uhevaha is researching how disease causing factors that cause preeclampsia are released from the preeclamptic placenta. Her vision is that a better understanding of these mechanisms will help us find new therapeutics for this disease. She is also involved in a drug-screening pipeline to identify new treatments for preeclampsia. With Fiona Brownfoot and others within The Translational Obstetrics Group, her sub-group identified the potential for metformin to prevent or treat preeclampsia.
She has published widely in many areas, but notably in the areas of ectopic pregnancy and preeclampsia. She has attracted over $4 million dollars in grant funding that have supported her research efforts. Dr Kaitu’u-Lino is currently a named investigator on four major NHMRC project grants.
Tu’uhevaha is also passionate about communicating science to the public. In recognition of this, she was awarded Victorian Tall Poppy of the Year in 2012. Since that award, she has been a mentor in the Growing Junior Tall Poppies program. She is also an active contributor to the scientific community, having previously served on The Board of the Australian Society for Medical Research and is now a council member for The Society for Reproductive Biology.
Tu’uhe graduated from her PhD in 2008 from Monash University. She is holds a Career Development Fellowship from the National Health and Medical Research Council of Australia.